Año 2022 / Volumen 114 / Número 7
Original
Clinical and pathological features of undifferentiated pancreatic carcinoma with osteoclastic giant cells: a rare case

395-399

DOI: 10.17235/reed.2021.8135/2021

Huijiang Shao, Baochun Lu, Xuezheng Sun, Fang Liu,

Resumen
Introduction: undifferentiated pancreatic carcinoma with osteoclastic giant cells (UOC) is a rare pancreatic malignancy composed of three unique cell types. Currently, the histopathologic origin of UOCs remains unclear. Some studies considered that it was differentiated from epithelial tissues, while others favored a mesenchymal derivation. Methods: we present the case of a 59-year-old UOC patient with a tumor (3.0 cm × 3.0 cm × 2.5 cm) in the pancreatic neck. He underwent an en bloc resection of the distal pancreas associated with the spleen. Results: light microscopic examination revealed two typical types of UOC cells, with one type absent. The immunohistochemical staining was positive for pancytokeratin, epithelial membrane antigen, vimentin and cluster of differentiation 68, which indicated different derivations for these two kinds of cells. Discussion: UOC is a rare condition with unique imaging and pathological features. Endoscopic ultrasonography and fine needle aspiration are dispensable preoperatively. Radical resection should be tried for UOC treatments. In our opinion, osteoclastic giant cells are reactive cells derived from histocytes. The case presented here will be of interest to the whole UOC cohort.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Burkadze G, Turashvili G. A case of osteoclast-like giant cell tumor of the pancreas associated with borderline mucinous cystic neoplasm. Pathol Oncol Res. 2009;15:129-31.
2. Sommers SC, Meissner WA. Unusual carcinomas of the pancreas. AMA Arch Pathol. 1954;58:101-11.
3. Fukushima N HR, Kato Y, et al. Ductal adenocarcinoma variants and mixed neoplasms of the pancreas. In: Bosman FT CF, Hruban RH, et al, eds, editor. World Health Organization Classification of Tumours of the Digestive Tract: Lyon, France: IARC Press; 2010. 292-5 p.
4. Jo S. Huge undifferentiated carcinoma of the pancreas with osteoclast-like giant cells. World J Gastroenterol. 2014;20:2725-30.
5. Reid MD, Muraki T, HooKim K, et al. Cytologic features and clinical implications of undifferentiated carcinoma with osteoclastic giant cells of the pancreas: An analysis of 15 cases. Cancer Cytopathol. 2017;125:563-75.
6. Lukás Z, Dvorák K, Kroupová I, et al. Immunohistochemical and genetic analysis of osteoclastic giant cell tumor of the pancreas. Pancreas. 2006;32:325-9.
7. Muraki T, Reid MD, Basturk O, et al. Undifferentiated Carcinoma With Osteoclastic Giant Cells of the Pancreas: Clinicopathologic Analysis of 38 Cases Highlights a More Protracted Clinical Course Than Currently Appreciated. Am J Surg Pathol. 2016;40:1203-16.
8. Rustagi T, Rampurwala M, Rai M, et al. Recurrent acute pancreatitis and persistent hyperamylasemia as a presentation of pancreatic osteoclastic giant cell tumor: an unusual presentation of a rare tumor. Pancreatology. 2011;11:12-5.
9. Moore JC, Hilden K, Bentz JS, et al. Osteoclastic and pleomorphic giant cell tumors of the pancreas diagnosed via EUS-guided FNA: unique clinical, endoscopic, and pathologic findings in a series of 5 patients. Gastrointest Endosc. 2009;69:162-6.
10. Singhal A, Shrago SS, Li SF, et al. Giant cell tumor of the pancreas: a pathological diagnosis with poor prognosis. Hepatobiliary Pancreat Dis Int. 2010;9:433-7.
11. Sah SK, Li Y, Li Y. Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a rare case report and review of the literature. Int J Clin Exp Pathol. 2015;8:11785-91.
12. Fu LP, Cheng AP, Wang XG, et al. 18F-FDG PET/CT in the Detection of Undifferentiated Carcinoma With Osteoclast-like Giant Cells of the Pancreas. Clin Nucl Med. 2017;42:615-6.
13. Abid H, Gnanajothy R. Osteoclast Giant Cell Tumor of Pancreas: A Case Report and Literature Review. Cureus. 2019;11:e4710.
14. Moore JC, Bentz JS, Hilden K, et al. Osteoclastic and pleomorphic giant cell tumors of the pancreas: A review of clinical, endoscopic, and pathologic features. World J Gastrointest Endosc. 2010;2:15-9.
15. Temesgen WM, Wachtel M, Dissanaike S. Osteoclastic giant cell tumor of the pancreas. Int J Surg Case Rep. 2014;5:175-9.
16. Saito H, Kashiyama H, Murohashi T, et al. Case of Six-Year Disease-Free Survival with Undifferentiated Carcinoma of the Pancreas. Case Rep Gastroenterol. 2016;10:472-8.
17. Shi W, Indelicato DJ, Reith J, et al. Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol. 2013;36:505-8.
18. Gocke CD, Dabbs DJ, Benko FA, et al. KRAS oncogene mutations suggest a common histogenetic origin for pleomorphic giant cell tumor of the pancreas, osteoclastoma of the pancreas, and pancreatic duct adenocarcinoma. Hum Pathol. 1997;28:80-3.
19. Hoorens A, Prenzel K, Lemoine NR, et al. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin. J Pathol. 1998;185:53-60.
20. Goldberg RD, Michelassi F, Montag AG. Osteoclast-like giant cell tumor of the pancreas: immunophenotypic similarity to giant cell tumor of bone. Hum Pathol. 1991;22:618-22.
Artículos relacionados
Instrucciones para citar
Shao H, Lu B, Sun X, Liu F. Clinical and pathological features of undifferentiated pancreatic carcinoma with osteoclastic giant cells: a rare case. 8135/2021


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 998 veces.
Este artículo ha sido descargado 58 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 04/06/2021

Aceptado: 13/10/2021

Prepublicado: 19/10/2021

Publicado: 07/07/2022

Tiempo de revisión del artículo: 125 días

Tiempo de prepublicación: 137 días

Tiempo de edición del artículo: 398 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas